Company Overview - Medicskin Holdings Limited is a Hong Kong investment holding company primarily providing medical skin care services, founded by Dr. Jiang in 2000 [2] - The company operates two Medicskin centers in Hong Kong, focusing on treating skin diseases and improving appearance [2] - Services offered include treatment for acne, pigmentation, rosacea, eczema, warts, and aesthetic procedures such as skin rejuvenation and contouring [2] Financial Performance - As of September 30, 2025, Medicskin reported total revenue of HKD 20.79 million, a year-on-year increase of 1.97% [1] - The net profit attributable to shareholders was HKD 32,000, reflecting a significant year-on-year growth of 101.72% [1][3] - The gross profit margin stood at 81.58%, while the debt-to-asset ratio was 91.54% [1] Market Position and Valuation - Medicskin's current price-to-earnings (P/E) ratio is -40.01, ranking 77th in its industry, compared to the average P/E ratio of 4.68 for other healthcare companies [1] - Other companies in the healthcare sector have P/E ratios such as Jingjiu Kangliao at 1.53, Yihui Group at 2.84, and Global Medical at 5.54 [1] Stock Performance - As of November 28, the Hang Seng Index fell by 0.34%, while Medicskin's stock price increased by 12.12% to HKD 0.148 per share, with a trading volume of 8,000 shares [1] - Over the past month, Medicskin's stock has declined by 32.65%, and year-to-date, it has decreased by 12%, underperforming the Hang Seng Index's increase of 29.34% [1] Institutional Ratings - Currently, there are no investment rating recommendations from institutions for Medicskin [1]

Company Overview - Medicskin Holdings Limited is a Hong Kong investment holding company primarily providing medical skin care services, founded by Dr. Jiang in 2000 [2] - The company operates two Medicskin centers in Hong Kong, focusing on treating skin diseases and improving appearance [2] - Services offered include treatment for acne, pigmentation, rosacea, eczema, warts, and aesthetic procedures such as skin rejuvenation and contouring [2] Financial Performance - As of September 30, 2024, Medicskin reported total revenue of 20.14 million HKD, a year-on-year decrease of 9.05% [1] - The company recorded a net profit attributable to shareholders of -1.83 million HKD, an increase of 4.24% year-on-year [1] - The gross profit margin stands at 82.16%, with a debt-to-asset ratio of 88.7% [1] Market Position and Valuation - Medicskin's price-to-earnings (P/E) ratio is -20.39, ranking 68th in the healthcare equipment and services industry, which has an average P/E ratio of -20.99 [1] - Other companies in the industry include Giant Medical Holdings (0.33), Kingjoy Health (0.38), Yongsheng Medical (4.39), Global Medical (4.51), and Ruici Medical (5.15) [1] Upcoming Events - The company is scheduled to disclose its annual report for the fiscal year 2024 on June 23, 2025 [3]